Global Med Technologies(R), Inc. Signs Nationwide Contract With Nigeria
June 29 2005 - 11:00AM
PR Newswire (US)
Global Med Technologies(R), Inc. Signs Nationwide Contract With
Nigeria Global Med to Install SafeTrace(R) and SafeTrace Tx(R)*
Throughout Nigeria DENVER, June 29 /PRNewswire-FirstCall/ --
Wyndgate Technologies(R) ("Wyndgate"), a division of Global Med
Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global
Med" or the "Company"), announced the signing of a nationwide
contract with Nigeria for its SafeTrace(R) donor management system
and SafeTrace Tx(R) advanced transfusion management system. Nigeria
is the largest country by population in Africa, with approximately
130 million people. Terms of the contract were not disclosed.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
Global Med will be working very closely with Safe Blood for
Africa(TM) Foundation ("SBFA") as SBFA establishes, upgrades and
operates the Nigeria National Blood Transfusion Service in
collaboration with the Federal Ministry of Health. The agreement
will provide for the installation of Global Med's blood bank
information systems in each blood center operated by Safe Blood for
Africa Foundation. Stephen Field, M.D., Medical Director for Safe
Blood for Africa Foundation, said, "Blood centers in underdeveloped
countries face challenges beyond those in technologically-advanced
countries. Blood shortages are a concern and the blood supply is at
risk of possible contamination with blood- borne diseases, such as
HIV, hepatitis, syphilis, etc." Dr. Field continued, "Replacing
Nigeria's blood centers' manual processes and manual records with
automated solutions can help to manage Nigeria's donor testing and
help to ensure the safe release of blood and blood products for
transfusion. About six additional centers are interested in
installing Global Med Technologies this year alone. Global Med was
our first choice in world-wide blood donor and hospital transfusion
information systems." Will Willman, Senior Vice President of
International Business Development, stated, "Based on the success
of the installation of SafeTrace in Abuja, Nigeria, many other
centers in Nigeria were very eager for a similar information system
solution. The use of readily available satellite technology enables
a robust solution in the technologically challenged African
environment." Mr. Willman added, "This nationwide contract and
implementation of Global Med's donor and hospital transfusion
systems via satellite throughout the country of Nigeria is an
indication of Global Med's ability to provide its software to
entire countries, not only in Africa, but throughout the world. In
addition, the quality of our products and the competency of our
employees provide the foundation for future installations in
international markets. The international market affords a $500+
million dollar opportunity for Global Med." About Global Med
Technologies, Inc. Global Med Technologies, Inc. is an
international e-Health, medical information technology company,
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers.
Current clients of Wyndgate's products and services manage more
than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Wyndgate's products are also being implemented
in Canada, the Caribbean and sub-Saharan Africa. Together, the
SafeTrace donor management system and the SafeTrace Tx(R)* advanced
transfusion management system provide Vein-to-Vein(R) tracking from
donor collection to patient transfusion. For more information about
Global Med's products and services, please call 800-WYNDGATE or
visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. *Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies(R),
Inc., +1-303-238-2000; or investor relations, John Nesbett, or
Jordan Silverstein, both of The Investor Relations Group,
+1-212-825-3210, for Global Med Technologies, Inc. Web site:
http://www.globalmedtech.com/ http://www.peoplemed.com/
http://www.wyndgate.com/
Copyright